Georgios G.
- Country
- Greece
- Department
- Department of Internal Medicine
Research Overview
- Efficacy of Pancreatic Stone Protein-Guided Early Meropenem Administration to Mitigate Sepsis Risk in Patients Presenting to the Emergency Department: A Phase III RCT
- Biomarker-Guided Early Clarithromycin Administration to Prevent Sepsis Progression in Community-Acquired Pneumonia: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 7 of 21 partner sites.
Specializations
Community-acquired pneumonia and sepsis prevention
Clinical research activity centers on community-acquired pneumonia with a strong focus on preventing progression to sepsis in patients at elevated risk. The work is closely tied to early therapeutic intervention in the setting of acute respiratory infection.
- Adjunctive clarithromycin treatment
- Biomarker-guided infection risk assessment
- Sepsis progression prevention
Interest in this area reflects a therapeutic emphasis on timely antimicrobial support for patients with pneumonia who may deteriorate into systemic infection.
Infection and emergency sepsis management
Another major area of involvement is the early management of suspected infection in the emergency setting, with attention to patients at risk of death and rapid clinical decline. The research landscape includes treatment strategies aimed at improving outcomes in acute infectious illness.
- Early meropenem intervention
- Emergency department infection care
- High-risk sepsis mitigation
This therapeutic domain places emphasis on prompt antibacterial escalation for unstable patients with suspected severe infection.
Biomarker-guided therapeutic decision-making
The investigator’s clinical research also includes biomarker-guided treatment selection, using laboratory indicators to support earlier identification of patients who may benefit from targeted antimicrobial therapy. This area links diagnostic stratification with immediate clinical action.
- suPAR-guided treatment selection
- Pancreatic stone protein (PSP)
- Risk stratification in acute infection
These interests align with precision-oriented care in infectious disease management, especially where early intervention may alter disease trajectory.
Internal medicine and acute infectious disease care
Within the Department of Internal Medicine at the General Hospital of Syros, the clinical focus remains on acute infectious syndromes requiring rapid assessment and treatment. The portfolio is concentrated on hospital-based care for patients with pneumonia or suspected systemic infection.
- Hospital-based infection management
- Acute respiratory infection
- Sepsis-risk triage
These areas reflect a sustained therapeutic interest in improving outcomes for medically unstable patients through early infection-directed care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.